BIO vs NVEC · rev $2.58B vs P/E 35, rev $25.9M
BIO (BIO) versus NVE Corporation (NVEC) — a side-by-side from cached financials, not a winner call.
BIO (BIO) common stock.
NVE Corporation (NVEC) is a semiconductors company listed on US.
Latest reported BIO revenue for 2025-12-31 was $2.58B. Net income was $759.9M. Revenue was up 0.7% from 2024-12-31 to 2025-12-31. BIO currently screens at market cap $0.
Latest reported NVEC revenue for 2025-03-31 was $25.9M. Net income was $15.1M. Revenue was down 13.2% from 2024-03-31 to 2025-03-31. NVEC currently screens at market cap $527.6M and trailing P/E 34.7.
BIO currently screens at market cap $0. NVEC currently screens at market cap $527.6M and trailing P/E 34.7.
Not investment advice. Open the BIO and NVEC stock pages for the full models.
Not investment advice.